Adoptively transferred, tumour-specific CD8+ T cells were activated and recruited to the site of tumour inoculation and gave rise to TRM cells expressing the canonical tissue-retentive molecules CD69 and CD103. The gene discussed is CD8A; the disease is neoplasm.